VMware, Inc. (NYSE:VMW) Short Interest Update

Share on StockTwits

VMware, Inc. (NYSE:VMW) was the target of a significant drop in short interest in November. As of November 15th, there was short interest totalling 7,730,000 shares, a drop of 6.0% from the October 31st total of 8,220,000 shares. Currently, 10.2% of the shares of the company are sold short. Based on an average daily trading volume, of 1,480,000 shares, the days-to-cover ratio is presently 5.2 days.

NYSE:VMW opened at $155.62 on Monday. VMware has a 1 year low of $128.69 and a 1 year high of $206.80. The firm has a 50 day moving average of $160.80 and a 200-day moving average of $164.09. The company has a current ratio of 0.96, a quick ratio of 0.96 and a debt-to-equity ratio of 0.93. The stock has a market capitalization of $65.85 billion, a P/E ratio of 31.57, a price-to-earnings-growth ratio of 2.39 and a beta of 0.92.

VMware (NYSE:VMW) last posted its earnings results on Tuesday, November 26th. The virtualization software provider reported $1.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.43 by $0.06. VMware had a net margin of 67.21% and a return on equity of 88.87%. The company had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter in the previous year, the company posted $1.56 earnings per share. VMware’s quarterly revenue was up 11.6% compared to the same quarter last year. As a group, analysts forecast that VMware will post 4.87 EPS for the current fiscal year.

A number of brokerages have commented on VMW. Jefferies Financial Group cut their price target on shares of VMware from $198.00 to $180.00 and set a “buy” rating for the company in a research note on Tuesday, October 8th. Wedbush set a $210.00 price target on shares of VMware and gave the stock a “buy” rating in a research note on Friday, August 23rd. Stifel Nicolaus raised their price target on shares of VMware from $150.00 to $178.00 and gave the stock a “hold” rating in a research note on Wednesday, November 27th. Royal Bank of Canada raised their price target on shares of VMware from $190.00 to $200.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 27th. Finally, Bank of America restated a “buy” rating and set a $190.00 price target on shares of VMware in a research note on Thursday. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and fourteen have assigned a buy rating to the company. VMware currently has a consensus rating of “Hold” and an average price target of $178.30.

In other VMware news, VP Amy Fliegelman Olli sold 2,753 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $150.00, for a total transaction of $412,950.00. Following the completion of the transaction, the vice president now owns 38,728 shares in the company, valued at $5,809,200. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Rangarajan (Raghu) Raghuram sold 24,712 shares of the firm’s stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $163.53, for a total transaction of $4,041,153.36. Following the transaction, the chief operating officer now owns 221,977 shares of the company’s stock, valued at approximately $36,299,898.81. The disclosure for this sale can be found here. Over the last three months, insiders have sold 104,109 shares of company stock worth $15,837,960. 28.80% of the stock is owned by company insiders.

Several large investors have recently bought and sold shares of the company. Amundi Pioneer Asset Management Inc. raised its position in VMware by 51.6% in the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 56,248 shares of the virtualization software provider’s stock worth $10,153,000 after purchasing an additional 19,154 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its position in VMware by 65.7% in the 2nd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,009 shares of the virtualization software provider’s stock worth $169,000 after purchasing an additional 400 shares during the last quarter. Commonwealth Equity Services LLC raised its position in VMware by 41.2% in the 2nd quarter. Commonwealth Equity Services LLC now owns 9,008 shares of the virtualization software provider’s stock worth $1,506,000 after purchasing an additional 2,629 shares during the last quarter. Robeco Institutional Asset Management B.V. raised its position in VMware by 48.2% in the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 199,185 shares of the virtualization software provider’s stock worth $33,302,000 after purchasing an additional 64,822 shares during the last quarter. Finally, SeaCrest Wealth Management LLC raised its position in VMware by 154.3% in the 2nd quarter. SeaCrest Wealth Management LLC now owns 1,195 shares of the virtualization software provider’s stock worth $200,000 after purchasing an additional 725 shares during the last quarter. Institutional investors own 16.87% of the company’s stock.

About VMware

VMware, Inc provides software in the areas of hybrid cloud, multi-cloud, modern applications, networking and security, and digital workspaces in the United States and internationally. The company offers compute products, including VMware vSphere, a data center platform, which enables users to deploy hypervisor, a layer of software that resides between the operating system and system hardware to enable compute virtualization; and cloud management products for businesses with automated operation, programmable provisioning, and application monitoring solutions.

Recommended Story: Yield Curve

Receive News & Ratings for VMware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VMware and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.